These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8180332)
1. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Michelson AD Blood Coagul Fibrinolysis; 1994 Feb; 5(1):121-31. PubMed ID: 8180332 [TBL] [Abstract][Full Text] [Related]
2. Effect of strenuous exercise on platelet activation state and reactivity. Kestin AS; Ellis PA; Barnard MR; Errichetti A; Rosner BA; Michelson AD Circulation; 1993 Oct; 88(4 Pt 1):1502-11. PubMed ID: 8403298 [TBL] [Abstract][Full Text] [Related]
3. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine. Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701 [TBL] [Abstract][Full Text] [Related]
4. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Colace TV; Muthard RW; Diamond SL Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1466-76. PubMed ID: 22516070 [TBL] [Abstract][Full Text] [Related]
5. Interaction of the protein C activation peptide with platelets. Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824 [TBL] [Abstract][Full Text] [Related]
6. Comparison of beta-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation. Matzdorff AC; Kemkes-Matthes B; Voss R; Pralle H Haemostasis; 1996; 26(2):98-106. PubMed ID: 9119289 [TBL] [Abstract][Full Text] [Related]
7. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents. Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085 [TBL] [Abstract][Full Text] [Related]
8. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560 [TBL] [Abstract][Full Text] [Related]
9. Human neutrophil cathepsin G is a potent platelet activator. LaRosa CA; Rohrer MJ; Benoit SE; Rodino LJ; Barnard MR; Michelson AD J Vasc Surg; 1994 Feb; 19(2):306-18; discussion 318-9. PubMed ID: 7509416 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist. Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957 [TBL] [Abstract][Full Text] [Related]
11. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets. Chronos NA; Wilson DJ; Janes SL; Hutton RA; Buller NP; Goodall AH Clin Sci (Lond); 1994 Nov; 87(5):575-80. PubMed ID: 7533066 [TBL] [Abstract][Full Text] [Related]
12. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb. Jarvis GE; Atkinson BT; Frampton J; Watson SP Br J Pharmacol; 2003 Feb; 138(4):574-83. PubMed ID: 12598411 [TBL] [Abstract][Full Text] [Related]
13. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity. Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of collagen-induced platelet aggregation by argatroban in patients with acute cerebral infarction. Imiya M; Matsuo T Thromb Res; 1997 Oct; 88(2):245-50. PubMed ID: 9361377 [TBL] [Abstract][Full Text] [Related]
15. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor. Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080 [TBL] [Abstract][Full Text] [Related]
16. Platelet activation by Protease I of Porphyromonas gingivalis W83. Curtis MA; Macey M; Slaney JM; Howells GL FEMS Microbiol Lett; 1993 Jun; 110(2):167-73. PubMed ID: 8394260 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation. Burke FM; Warnock M; Schmaier AH; Mosberg HI Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882 [TBL] [Abstract][Full Text] [Related]
18. YD-3, a novel inhibitor of protease-induced platelet activation. Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968 [TBL] [Abstract][Full Text] [Related]
19. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. Li N; Hu H; Hjemdahl P Thromb Res; 2003; 111(3):165-70. PubMed ID: 14678815 [TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of platelet aggregation by fibrinogen-related peptides. Adelman B; Gennings C; Strony J; Hanners E Circ Res; 1990 Oct; 67(4):941-7. PubMed ID: 2208617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]